Remove Ablation Remove Atrial Fibrillation Remove Pacemaker
article thumbnail

UC San Diego Health First in Region to Implant Dual Chamber, Leadless Pacemaker

DAIC

UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heart rhythms. Holding the device and pictured above is Ulrika Birgersdotter-Green, MD, cardiologist and director of pacemaker and ICD services at UC San Diego Health.

Pacemaker 105
article thumbnail

PO-02-019 DEFINING THE RISK OF CONCOMITANT PACEMAKER IMPLANTATION AND AV NODE ABLATION FOR ATRIAL FIBRILLATION – A PROBABILITY-BASED APPROACH

HeartRhythm

Pacemaker implantation and AV node ablation (AVNA) is central to the management of drug refractory atrial fibrillation. AVNA is either performed on the same day as pacemaker implantation, or is deferred by six weeks to preclude poor outcomes resulting from lead dislodgements within that period.

article thumbnail

PO-06-180 SAME SITTING PACE AND ABLATE USING THE ABBOTT AVEIRTM LEADLESS DR PACEMAKER – FIRST-IN-MAN EXPERIENCE

HeartRhythm

Permanent pacemaker implantation followed by atrio-ventricular node ablation (AVNA) is a well-recognized two stage procedure for rate control in patients with symptomatic atrial fibrillation (AF).

article thumbnail

MP-470549-006 CLINICAL PREDICTORS OF RHYTHM RESTORATION FOLLOWING CONDUCTION SYSTEM PACING AND ATRIOVENTRICULAR JUNCTION ABLATION IN PATIENTS WITH REFRACTORY ATRIAL FIBRILLATION

HeartRhythm

Atrioventricular junction (AVJ) ablation is reserved for patients with refractory uncontrolled atrial fibrillation despite antiarrhythmic drug use or ablation. Atrial lead implant is uncommon during pacemaker implant at the time of AVJ ablation.

article thumbnail

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

DAIC

16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. 2024, May 15).

AFIB 52
article thumbnail

Atrioventricular Node Ablation for Atrial Fibrillation in a Patient With EVOQUE Tricuspid Valve: A First Reported Case

Journal of Cardiovascular Electrophysiology

ABSTRACT Introduction Atrial fibrillation (AF) is the most common arrhythmia, and atrioventricular (AV) node ablation with pacemaker implantation is a therapeutic option for refractory cases. However, AV node ablation in patients with bioprosthetic tricuspid valves poses technical challenges.

article thumbnail

Surgical treatment of atrial fibrillation in elderly patients undergoing high risk cardiac surgery

Journal of Cardiothoracic Surgery

Mehods We retrospectively identified patients aged over 70 years with Atrial Fibrillation (AF) from 2011 to 2017 who had two or more other cardiac procedures. Cox-Maze IV AF ablation. No differences observed in freedom from stroke (p = 0.80) or permanent pacemaker (p = 0.33) between the groups.